Still in the early days of June and weeks away from the northern hemisphere's summer solstice, the climate for financings is heating up in the U.S. Three biopharmas – Mersana Therapeutics Inc., Aileron Therapeutics Inc. and Dova Pharmaceuticals Inc. – have filed for U.S. IPOs since the start of the month. A fourth, Athenex Inc., filed May 12 and set terms last week.